The STAR trial: Evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women

Therese B. Bevers

Research output: Contribution to journal › Review article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'The STAR trial: Evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women'. Together they form a unique fingerprint.

Medicine & Life Sciences